Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -0.33%5.87B | -2.19%5.89B | -2.45%1.72B | -8.88%1.43B | -3.63%1.33B | 7.67%1.41B | 11.45%6.02B | 4.67%1.76B | 14.08%1.57B | 15.43%1.38B |
| Cost of revenue | -0.39%4.13B | -1.75%4.15B | -3.83%1.2B | -6.70%1.01B | -2.86%943.07M | 8.10%993.14M | 15.33%4.22B | 8.20%1.24B | 18.27%1.09B | 20.47%970.83M |
| Gross profit | -0.19%1.74B | -3.22%1.74B | 0.89%521.38M | -13.82%413.31M | -5.46%386.98M | 6.65%418.87M | 3.29%1.8B | -2.94%516.8M | 5.59%479.6M | 5.01%409.34M |
| Operating expense | -0.53%1.47B | -0.23%1.48B | -9.37%372.22M | 4.98%378.43M | 1.61%367.97M | 3.22%362.52M | 2.90%1.48B | 3.34%410.7M | 1.67%360.49M | 3.28%362.15M |
| Selling and administrative expenses | -0.53%1.47B | -0.23%1.48B | ---- | ---- | ---- | ---- | 2.90%1.48B | ---- | ---- | ---- |
| -Selling and marketing expense | 4.05%343.72M | -4.18%330.33M | ---- | ---- | ---- | ---- | 12.23%344.73M | ---- | ---- | ---- |
| -General and administrative expense | -1.85%1.13B | 0.96%1.15B | ---- | ---- | ---- | ---- | 0.37%1.14B | ---- | ---- | ---- |
| Operating profit | 1.79%264.06M | -17.37%259.41M | 40.59%149.16M | -70.71%34.89M | -59.72%19.01M | 35.70%56.36M | 5.22%313.93M | -21.42%106.1M | 19.57%119.11M | 20.40%47.19M |
| Net non-operating interest income (expenses) | -115.36%-5.66M | -73.71%-2.63M | -48.30%-829K | -115.95%-704K | -82.13%-581K | -66.45%-516K | 21.88%-1.51M | -37.01%-559K | 25.57%-326K | 38.77%-319K |
| Non-operating interest income | 535.00%254K | 48.15%40K | 28.57%9K | 57.14%11K | 42.86%10K | 66.67%10K | -6.90%27K | 450.00%7K | -66.67%7K | 0.00%7K |
| Non-operating interest expense | 121.65%5.92M | 73.26%2.67M | 48.06%838K | 114.71%715K | 81.29%591K | 66.46%526K | -21.66%1.54M | 39.41%566K | -27.45%333K | -38.26%326K |
| Net investment income | 24.89%1.14M | 33.14%912K | 0 | 0 | 0 | 33.14%912K | 0.00%685K | 0 | 0 | 0 |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -90.89%1.17M | -31.42%12.84M | -84.85%2.84M | 10M | 0 | 0 | 259.04%18.72M | 727.41%18.72M | 0 | 0 |
| Less:Other special charges | 90.89%-1.17M | 31.42%-12.84M | ---2.84M | ---- | ---- | ---- | -259.04%-18.72M | ---- | ---- | ---- |
| Other non-operating income (expenses) | -230.04%-2.47M | 70.38%-749K | -6.06%-945K | 74.12%-161K | -286.31%-649K | 218.63%1.01M | -72.39%-2.53M | -296.26%-891K | 43.61%-622K | -278.72%-168K |
| Income before tax | -4.28%258.23M | -18.07%269.78M | 21.77%150.22M | -62.75%44.02M | -61.93%17.78M | 40.68%57.76M | 16.00%329.29M | -10.16%123.36M | 41.08%118.17M | 19.58%46.71M |
| Income tax | -3.07%83.2M | 11.74%85.84M | 543.93%41.51M | -60.71%15.62M | -59.35%7.62M | 77.51%21.09M | -21.36%76.81M | -86.20%6.45M | 33.13%39.74M | 23.12%18.74M |
| Net income | -4.85%175.03M | -27.15%183.94M | -7.02%108.71M | -63.78%28.41M | -63.66%10.16M | 25.67%36.66M | 35.60%252.48M | 29.04%116.92M | 45.47%78.43M | 17.33%27.96M |
| Net income continuous operations | -4.85%175.03M | -27.15%183.94M | -7.02%108.71M | -63.78%28.41M | -63.67%10.16M | 25.68%36.66M | 35.59%252.48M | 29.04%116.92M | 45.48%78.43M | 17.32%27.96M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -4.85%175.03M | -27.15%183.94M | -7.02%108.71M | -63.78%28.41M | -63.66%10.16M | 25.67%36.66M | 35.60%252.48M | 29.04%116.92M | 45.47%78.43M | 17.33%27.96M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -4.85%175.03M | -27.15%183.94M | -7.02%108.71M | -63.78%28.41M | -63.66%10.16M | 25.67%36.66M | 35.60%252.48M | 29.04%116.92M | 45.47%78.43M | 17.33%27.96M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -5.14%46.31 | -27.43%48.82 | -7.39%28.84 | -63.91%7.54 | -63.84%2.69 | 25.00%9.75 | 34.89%67.27 | 28.36%31.14 | 44.67%20.89 | 16.61%7.44 |
| Diluted earnings per share | -5.14%46.31 | -27.43%48.82 | -7.33%28.8241 | -63.95%7.5313 | -63.84%2.69 | 25.00%9.75 | 34.89%67.27 | 28.48%31.105 | 44.67%20.89 | 16.61%7.44 |
| Dividend per share | 31.25%21 | 0.00%16 | 0.00%16 | 0 | 0 | 0 | 6.67%16 | 6.67%16 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |